| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |